• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

两名老年患者出现非明显的创伤后危及生命的出血。

Non-Obvious, Post-Traumatic, Life-Threatening Bleeding in Two Elderly Patients.

作者信息

Carretero Rafael García

机构信息

Internal Medicine Department, Mostoles University Hospital, Mostoles, Spain.

出版信息

J Crit Care Med (Targu Mures). 2017 May 11;3(2):79-83. doi: 10.1515/jccm-2017-0012. eCollection 2017 Apr.

DOI:10.1515/jccm-2017-0012
PMID:29967876
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5769913/
Abstract

The main complication of anticoagulant therapy is major bleeding. Clinicians are usually aware of these side effects and are careful when managing the therapeutic range of vitamin K antagonist drugs. But major bleeding, while life-threatening, can be overlooked if there are no visible signs of bleeding. Two cases are described in which inaccurate diagnoses lead to inadequate treatment.

摘要

抗凝治疗的主要并发症是严重出血。临床医生通常了解这些副作用,在管理维生素K拮抗剂药物的治疗范围时会很谨慎。但是严重出血虽然危及生命,如果没有明显的出血迹象,可能会被忽视。本文描述了两例因诊断不准确导致治疗不足的病例。

相似文献

1
Non-Obvious, Post-Traumatic, Life-Threatening Bleeding in Two Elderly Patients.两名老年患者出现非明显的创伤后危及生命的出血。
J Crit Care Med (Targu Mures). 2017 May 11;3(2):79-83. doi: 10.1515/jccm-2017-0012. eCollection 2017 Apr.
2
Prothrombin Complex Concentrates for Perioperative Vitamin K Antagonist and Non-vitamin K Anticoagulant Reversal.用于围手术期维生素 K 拮抗剂和非维生素 K 抗凝剂逆转的凝血酶原复合物浓缩物。
Anesthesiology. 2018 Dec;129(6):1171-1184. doi: 10.1097/ALN.0000000000002399.
3
Reversal agents for oral anticoagulant-associated major or life-threatening bleeding.口服抗凝剂相关的主要或危及生命的出血的逆转剂。
Intern Emerg Med. 2019 Nov;14(8):1233-1239. doi: 10.1007/s11739-019-02177-2. Epub 2019 Aug 24.
4
Major Bleeding Rates in Atrial Fibrillation Patients on Single, Dual, or Triple Antithrombotic Therapy.房颤患者采用单药、双联或三联抗栓治疗的大出血发生率。
Circulation. 2019 Feb 5;139(6):775-786. doi: 10.1161/CIRCULATIONAHA.118.036248.
5
Limb-threatening Deep Venous Thrombosis Complicating Warfarin Reversal with Three-factor Prothrombin Complex Concentrate: A Case Report.使用三因子凝血酶原复合物浓缩物逆转华法林治疗并发肢体威胁性深静脉血栓形成:一例报告
J Emerg Med. 2016 Jan;50(1):28-31. doi: 10.1016/j.jemermed.2015.02.053. Epub 2015 Oct 24.
6
Prothrombin complex concentrate for vitamin K antagonist reversal in acute bleeding settings: efficacy and safety.用于急性出血情况下维生素 K 拮抗剂逆转的凝血酶原复合物浓缩物:疗效和安全性。
Expert Rev Hematol. 2019 Jul;12(7):525-540. doi: 10.1080/17474086.2019.1624520. Epub 2019 Jun 17.
7
Prothrombin Complex Concentrate for Intracerebral Hemorrhage Secondary to Vitamin K Deficiency Bleeding in a 6-Week-Old Child.用于6周龄儿童维生素K缺乏性出血继发脑出血的凝血酶原复合物浓缩剂
J Pediatr. 2015 Dec;167(6):1443-4. doi: 10.1016/j.jpeds.2015.09.030. Epub 2015 Oct 9.
8
Prothrombin complex concentrate versus placebo, no intervention, or other interventions in critically bleeding patients associated with oral anticoagulant administration: a protocol for a systematic review of randomised clinical trials with meta-analysis and trial sequential analysis.抗凝血剂治疗相关危重症出血患者中使用凝血酶原复合物浓缩物与安慰剂、无干预或其他干预措施的比较:一项系统评价随机临床试验的方案,包括荟萃分析和试验序贯分析。
Syst Rev. 2018 Oct 20;7(1):169. doi: 10.1186/s13643-018-0838-y.
9
Prevention of treatment-related fluid overload reduces estimated effective cost of prothrombin complex concentrate in patients requiring rapid vitamin K antagonist reversal.预防与治疗相关的液体超负荷可降低需要快速逆转维生素K拮抗剂的患者使用凝血酶原复合物浓缩剂的估计有效成本。
Expert Rev Pharmacoecon Outcomes Res. 2016;16(1):135-9. doi: 10.1586/14737167.2015.1071194. Epub 2015 Jul 25.
10
Bleeding risks associated with vitamin K antagonists.维生素 K 拮抗剂相关的出血风险。
Blood Rev. 2013 May;27(3):111-8. doi: 10.1016/j.blre.2013.02.004. Epub 2013 Mar 7.

本文引用的文献

1
Recommendations of diagnosis and treatment of pleural effusion. Update.胸腔积液的诊断与治疗建议。更新版。
Arch Bronconeumol. 2014 Jun;50(6):235-49. doi: 10.1016/j.arbres.2014.01.016. Epub 2014 Mar 31.
2
2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association.《2012欧洲心脏病学会心房颤动管理指南重点更新版:2010欧洲心脏病学会心房颤动管理指南更新》。由欧洲心律协会特别贡献制定。
Eur Heart J. 2012 Nov;33(21):2719-47. doi: 10.1093/eurheartj/ehs253. Epub 2012 Aug 24.
3
Evidence-based management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.基于证据的抗凝治疗管理:抗血栓治疗和血栓预防,第 9 版:美国胸科医师学会基于证据的临床实践指南。
Chest. 2012 Feb;141(2 Suppl):e152S-e184S. doi: 10.1378/chest.11-2295.
4
Practical management of coagulopathy associated with warfarin.华法林相关凝血病的实际管理
BMJ. 2010 Apr 19;340:c1813. doi: 10.1136/bmj.c1813.
5
Comparative pharmacokinetics of vitamin K antagonists: warfarin, phenprocoumon and acenocoumarol.维生素K拮抗剂的比较药代动力学:华法林、苯丙香豆素和醋硝香豆素。
Clin Pharmacokinet. 2005;44(12):1227-46. doi: 10.2165/00003088-200544120-00003.
6
Causes and management of pleural fibrosis.胸膜纤维化的病因与管理
Respirology. 2004 Nov;9(4):441-7. doi: 10.1111/j.1440-1843.2004.00630.x.